The Wall Street Journal reports that men seek genetic testing for inherited BRCA1 or BRCA2 mutations much less often than women.
Under a new partnership, Finnish DTC testing company Negen will send its raw genetic test data to BC Platforms to aid in reporting test results to clinicians.
Centrillion Technologies received a multimillion US dollar investment from WeDoctor while Centrillion Technologies Taiwan obtained a strategic investment from Arm IoT Fund.
An Associated Press poll finds that most US adults say they'd want to know whether they carried a gene variant predisposing them to an incurable disease.
Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.
CNBC reports that there are thousands of genetic tests available for consumers to chose between.
As part of the collaboration, B. Braun China founded a subsidiary, called B. Braun Precision Medicine Technology (BBPM), that opened in Shanghai in May.
The Slovenia-based firm will use the funds to develop its Health Intelligence platform, expand into Asian markets, and open an office in the UK.
Clinicians surveyed for a new study discussed how unvalidated genomic results could affect healthcare workflows and patients.
Federal officials are using DNA testing to reunite migrant families separated at the southern US border, CNN reports.
National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.
NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.
The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.
In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.